Thursday, 24 September 2009

New Student Group Study Room now available

Room KA- 206 in Kevin St Library may now be used by students for group study:

Monday: 10am - 3pm
Tuesday: 1pm - 8pm
Wednesday: 10am - 1pm
Thursday: 10am - 8pm
Friday: 3pm - 5pm
Saturday: 10am - 4pm

Don't forget the small group study room in the Snackery:

Monday-Thursday: 10am - 8pm
Friday: 10am - 5pm

Please book your time slot at the Kevin Street Library Desk (max 2 hrs)

Happy studying:-)

Monday, 21 September 2009


Another useful resource to complement Intute is Infomine - a collection of scholarly web resources. Fo Science see the PhySci, Bio & Med Sciences links on the Infomine wheel.

Monday, 14 September 2009

Library Opening Hours: New Semester

From Monday 21st September 09 Library Opening Hours in Kevin St are as follows:

  • Monday - Thursday: 9.30am-9.30pm
  • Friday: 9.30am-5.15pm
  • Saturday: 9.30am-4.30pm

Wednesday, 9 September 2009

Biology Image Library

The Biology Image Library is an online collection of images, movies, illustrations and animations across biology and biomedicine, for use in education and research. Developed by Biomed Central, an independent publishing company, the main subjects covered are:

Histology & Pathology
Microbiology & Parasitology
Molecular & Cellular Biology
Plant Biology

Friday, 4 September 2009

New Intute

Intute services, etutorials and a full listing of their subject resources booklets are now available at the new look website.

New cancer vaccine in the works

A new vaccine that may treat cancer and protect against the development of specific types of the disease could be on the market in the next five years. The research by US professor Albert Deisseroth should have major implications, not just for cancer treatment, but in vaccinating against influenzas and other infectious diseases. Prof Deisseroth explained that the response to cancer vaccines for the most common malignancies was limited because of defects in the immune system acquired over time. A way has been found to overcome this by giving a missing immune system protein at the time of vaccination. The new vaccine fuses the DNA of the missing protein with the target at which the vaccine is aimed, be it cancer cells or infectious viruses. The vaccine has overcome the defective response in older test subjects, prevented development of tumour formation and growth and stimulated an immune response against influenza. Michelle's McDonagh's full article is here.